13400 Participants Needed

Telehealth Support for Artificial Respiration

(TEACH Trial)

Recruiting at 10 trial locations
CB
CG
Overseen ByColin Grissom, MD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Intermountain Health Care, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial is testing a telehealth system called 'TEACH' to help doctors and nurses better manage the process of waking up and helping patients on ventilators breathe on their own. The goal is to improve patient outcomes by making it easier for healthcare providers to follow best practices.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Telehealth-enabled support for SAT/SBT adherence?

Research shows that telehealth technologies can improve adherence to treatment plans, as seen in studies with lung transplant recipients and COPD patients. These technologies help maintain high levels of adherence by providing immediate feedback, reminders, and simplifying communication between patients and healthcare providers.12345

Is telehealth support for artificial respiration generally safe for humans?

The research on telehealth systems for managing conditions like asthma and transplant adherence shows that these systems are generally well-accepted and safe, with participants finding them helpful and easy to use. No significant safety concerns were reported in the studies, and participants often experienced improved adherence and satisfaction with the telehealth interventions.16789

How is the Telehealth-enabled support for SAT/SBT adherence treatment different from other treatments for artificial respiration?

The Telehealth-enabled support for SAT/SBT adherence treatment is unique because it uses telehealth technology to enhance adherence to artificial respiration protocols by providing immediate feedback, reminders, and educational support, which can help maintain high adherence levels over time, unlike traditional methods that may not offer such interactive and continuous support.110111213

Research Team

CG

Colin Grissom, MD

Principal Investigator

Intermountain Health Care, Inc.

Eligibility Criteria

This trial is for patients aged 16 or older who are in the ICU and on artificial breathing support. It's not for those who passed away within a day of being put on a ventilator or were already brain dead when admitted for organ donation.

Inclusion Criteria

I am on a breathing machine.
I am 16 or older and currently in the ICU of the study hospital.

Exclusion Criteria

Patient who died within 24 hours of intubation
Patient with pre-existing brain death admitted to study hospital for organ donation

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive coordinated spontaneous awakening and breathing trials with telehealth-enabled support or usual audit and feedback

5 days
Daily monitoring during intubation

Follow-up

Participants are monitored for ventilator-free days and other clinical outcomes

28 days

Treatment Details

Interventions

  • Telehealth-enabled support for SAT/SBT adherence
  • Usual audit and feedback for SAT/SBT adherence
Trial OverviewThe study is testing if adding telehealth support to regular check-ups improves how well clinicians stick to protocols for waking up and breathing trials, which could lead to better outcomes for patients on ventilators.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention - Telehealth- enabled support plus usual audit and feedback for SAT/SBT adherenceExperimental Treatment2 Interventions
Usual audit and feedback + telehealth-enabled support
Group II: Control - Usual audit/feedback for SAT/SBT adherence onlyActive Control1 Intervention
Usual audit and feedback

Find a Clinic Near You

Who Is Running the Clinical Trial?

Intermountain Health Care, Inc.

Lead Sponsor

Trials
142
Recruited
1,965,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

University of Utah

Collaborator

Trials
1,169
Recruited
1,623,000+

Findings from Research

The Adherence Enhancement Internet Program (AEIP) was developed to improve long-term adherence to home monitoring among lung transplant recipients, addressing the common decline in adherence over time.
A feasibility trial with 12 lung transplant recipients showed that participants found the AEIP easy to use and acceptable, indicating it could be an effective tool for maintaining adherence to monitoring protocols.
The design of an Internet-based system to maintain home monitoring adherence by lung transplant recipients.Karl, BC., Finkelstein, SM., Robiner, WN.[2019]
Home telemonitoring technology significantly improved patient satisfaction and empowerment among patients with chronic obstructive pulmonary disease (COPD), as shown in a study comparing 23 telemonitoring patients to 23 traditional homecare patients.
While telemonitoring positively impacted patients' quality of life, it did not lead to expected savings in healthcare resources, indicating that simply implementing technology is not enough; a more comprehensive reorganization of care practices is needed.
Effects of home telemonitoring to support improved care for chronic obstructive pulmonary diseases.Sicotte, C., Parรฉ, G., Morin, S., et al.[2019]
A scoping review of 15 articles identified various care technologies aimed at improving medication adherence in organ transplant patients, with a focus on post-transplant settings.
The study highlights the need for patient-specific adaptations and training for these technologies, emphasizing that successful adherence interventions should also consider other aspects of post-transplant care beyond just medication.
Care Technologies to Improve Treatment Adherence in Patients Undergoing Organ Transplant: A Scoping Review.da Silva, AM., Knihs, NS., Sens, S., et al.[2022]

References

The design of an Internet-based system to maintain home monitoring adherence by lung transplant recipients. [2019]
Effects of home telemonitoring to support improved care for chronic obstructive pulmonary diseases. [2019]
Care Technologies to Improve Treatment Adherence in Patients Undergoing Organ Transplant: A Scoping Review. [2022]
Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence. [2020]
Significance of patient self-monitoring for long-term outcomes after lung transplantation. [2019]
Usability testing of the Internet program: "Teens Taking Charge: Managing My Transplant Online". [2019]
An Internet-based store-and-forward video home telehealth system for improving asthma outcomes in children. [2019]
Directly observed therapy to promote medication adherence in adolescent heart transplant recipients. [2022]
Internet-based home asthma telemonitoring: can patients handle the technology? [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
Telehealth Pulmonary Rehabilitation for Patients With Severe Chronic Obstructive Pulmonary Disease. [2020]
11.United Statespubmed.ncbi.nlm.nih.gov
Access to technology to support telehealth in areas without specialty care for liver disease. [2023]
A telehealth program for CPAP adherence reduces labor and yields similar adherence and efficacy when compared to standard of care. [2022]
The current use of telehealth in ALS care and the barriers to and facilitators of implementation: a systematic review. [2021]